BTG3 and rheumatic disorder: The development of Systemic and Dermatologic autoimmune diseases might be supported by the findings of systemic anti-nuclear antibodies (ANA) and anti-DNA (dsDNA) antibodies following TSCI, similar to those seen in rheumatism, systemic lupus erythematosus and autoimmune dermatologic diseases [7, 8].